ORIC-944 TFA

TargetMol Chemicals

ORIC-944 TFA

9

Research Use Only

ORIC-944 TFA is a selective, orally active conformational inhibitor that targets the EED subunit of polycomb repressive complex 2 (PRC2). It demonstrates synergistic effects when used in conjunction with androgen receptor pathway inhibitors (ARPI) in the study of metastatic prostate cancer.

-20°C

12352200